z-logo
open-access-imgOpen Access
Is Restoring Platinum Sensitivity the Best Goal for Cetuximab in Recurrent/Metastatic Nasopharyngeal Cancer?
Author(s) -
Lisa Licitra,
Paolo Bossi,
Laura D. Locati,
Cristiana Bergamini
Publication year - 2005
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2005.02.7854
Subject(s) - cetuximab , medicine , nasopharyngeal cancer , oncology , cancer , radiation therapy , colorectal cancer , nasopharyngeal carcinoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom